Published: May 12, 2021
Judy Fisher has been trying frantically to get a coronavirus vaccine appointment for her twin 12-year-olds. She has downloaded apps for every drugstore chain in New York City, is strategizing on multiple text chains and looking into out-of-state appointments, hoping to get her daughter and son fully vaccinated so they can see their friends and go to summer camp.
Published: May 11, 2021
WASHINGTON - The Food and Drug Administration cleared the first coronavirus vaccine for emergency use in children as young as 12 on Monday, expanding access to the Pfizer-BioNTech shot to adolescents before the next school year and marking another milestone in the nations battle with the virus.
Published: April 28, 2021
Public Health Minister Anutin Charnvirakul flatly denied a rumour on social media that American pharmaceutical company Pfizer had proposed to sell 13 million doses of its Covid-19 vaccine to Thailand four times but this was rejected by the government.
Published: March 30, 2021
BioNTech and Pfizer raised this year's production target for their covid-19 vaccine to as many as 2.5 billion doses, with the biotech's chief executive predicting a version of the shot that can be stored in refrigerators will be ready within months.
Published: March 11, 2021
BioNTech could have capacity to make 3 billion doses of covid-19 vaccine with U.S. partner Pfizer next year, the German company's chief executive officer said, making their pioneering shot far more widely available around the world.
Published: February 23, 2021
The Pfizer Inc. and BioNTech SE coronavirus vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing the first real-world indication that the immunization will curb transmission of the coronavirus.